← Back to Clinical Trials
Recruiting NCT07103109

NCT07103109 Impact of Proximal Motor Control Exercise on Scapular Muscles Activation Pattern Post Mastectomy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07103109
Status Recruiting
Phase
Sponsor Ahram Canadian University
Condition Post Mastectomy
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2025-08-05
Primary Completion 2026-06-10

Eligibility & Interventions

Sex Female only
Min Age 35 Years
Max Age 55 Years
Study Type INTERVENTIONAL
Interventions
Proximal stabilization exercisesConventional physical therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2025-08-05 with a primary completion date of 2026-06-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Mastectomy after breast cancer is usually accompanied by shoulder dysfunction which interferes with the daily life activities of the patients and causes physical and psychological impairments. This study aims to assess the impact of strength and stabilization exercise on scapular muscles activation pattern after mastectomy.

Eligibility Criteria

Inclusion Criteria: 1. Post-mastectomy female subjects. 2. Age between 35-55 years. 3. All patients have shoulder dysfunction (three months to four months post mastectomy). Exclusion Criteria: 1. Participants who have rheumatoid arthritis. 2. History of trauma or injuries. 3. Neurological deficits (stroke, Parkinsonism). 4. History of surgery on involved shoulder. 5. Diabetic patient. 6. Patients who rejected to participate in the trial, or to summit the formal consent form.

Contact & Investigator

Central Contact

Mahmoud Mohamed, Ph.D

✉ mahmoud.mohamed@fpt.bu.edu.eg

📞 01111750888

Principal Investigator

Mohamed Naeem, Ph.D

STUDY DIRECTOR

Faculty of Physical Therapy, Beni Sueif university

Frequently Asked Questions

Who can join the NCT07103109 clinical trial?

This trial is open to female participants only, aged 35 Years or older, up to 55 Years, studying Post Mastectomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07103109 currently recruiting?

Yes, NCT07103109 is actively recruiting participants. Contact the research team at mahmoud.mohamed@fpt.bu.edu.eg for enrollment information.

Where is the NCT07103109 trial being conducted?

This trial is being conducted at Giza, Egypt, Banhā, Egypt, Banī Suwayf, Egypt.

Who is sponsoring the NCT07103109 clinical trial?

NCT07103109 is sponsored by Ahram Canadian University. The principal investigator is Mohamed Naeem, Ph.D at Faculty of Physical Therapy, Beni Sueif university. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology